Fig. 2From: A novel stability-indicating chromatographic quantification of the antiparkinsonian drug safinamide in its pharmaceutical formulation employing HPTLC densitometry and ion-pair HPLC–DADThe suggested pathways for safinamide-induced degradationBack to article page
